These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35176950)

  • 61. SAVI SCOUT® localization of metastatic axillary lymph node prior to neoadjuvant chemotherapy for targeted axillary dissection: a pilot study.
    Baker JL; Haji F; Kusske AM; Fischer CP; Hoyt AC; Thompson CK; Lee MK; Attai D; DiNome ML
    Breast Cancer Res Treat; 2022 Jan; 191(1):107-114. PubMed ID: 34652548
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Total Tumor Load of mRNA Cytokeratin 19 in the Sentinel Lymph Node as a Predictive Value of Axillary Lymphadenectomy in Patients with Neoadjuvant Breast Cancer.
    Peña KB; Kepa A; Cochs A; Riu F; Parada D; Gumà J
    Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33435629
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Magnetic resonance lymphography of sentinel lymph nodes in patients with breast cancer using superparamagnetic iron oxide: a feasibility study.
    Shiozawa M; Kobayashi S; Sato Y; Maeshima H; Hozumi Y; Lefor AT; Kurihara K; Sata N; Yasuda Y
    Breast Cancer; 2014 Jul; 21(4):394-401. PubMed ID: 22926506
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer.
    Rubio IT; Cebrecos I; Peg V; Esgueva A; Mendoza C; Cortadellas T; Cordoba O; Espinosa-Bravo M; Xercavins J
    J Surg Oncol; 2012 Jul; 106(1):89-93. PubMed ID: 22258666
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
    Foster D; Choy N; Porter C; Ahmed S; Wapnir I
    J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Axillary and internal mammary sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy.
    Cao XS; Li HJ; Cong BB; Sun X; Qiu PF; Liu YB; Wang CJ; Wang YS
    Oncotarget; 2016 Nov; 7(45):74074-74081. PubMed ID: 27738336
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Axillary staging prior to neoadjuvant chemotherapy: the roles of sentinel lymph node biopsy and axillary ultrasonography.
    Lee MC; Joh JE; Chau A
    Cancer Control; 2012 Oct; 19(4):277-85. PubMed ID: 23037495
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trial.
    Houpeau JL; Chauvet MP; Guillemin F; Bendavid-Athias C; Charitansky H; Kramar A; Giard S
    J Surg Oncol; 2016 Apr; 113(5):501-7. PubMed ID: 26754343
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node (Pilot study).
    Eldweny H; Alkhaldy K; Alsaleh N; Abdulsamad M; Abbas A; Hamad A; Mounib S; Essam T; Kukawski P; Bobin JY; Oteifa M; Amanguono H; Abulhoda F; Usmani S; Elbasmy A
    J Egypt Natl Canc Inst; 2012 Mar; 24(1):23-30. PubMed ID: 23587229
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ultrasound-Guided Restaging and Localization of Axillary Lymph Nodes After Neoadjuvant Chemotherapy for Guidance of Axillary Surgery in Breast Cancer Patients: Experience with Activated Charcoal.
    Kim WH; Kim HJ; Jung JH; Park HY; Lee J; Kim WW; Park JY; Chae YS; Lee SJ
    Ann Surg Oncol; 2018 Feb; 25(2):494-500. PubMed ID: 29134374
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
    Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
    J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sentinel lymph node biopsy in a resourcelimited setting: a retrospective comparison of sentinel lymph node biopsy before and after the introduction of Sentimag at an academic breast unit.
    Yousef M; Roodt L; Masu A; Nel D; Malherbe F
    S Afr J Surg; 2023 Jun; 61(2):91-95. PubMed ID: 37381806
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Second echelon node predicts metastatic involvement of additional axillary nodes following sentinel node biopsy in early breast cancer.
    Bassi KK; Seenu V; Ballehaninna UK; Parshad R; Chumber S; Dhar A; Gupta SD; Kumar R; Srivastava A
    Indian J Cancer; 2006; 43(3):103-9. PubMed ID: 17065767
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localisation in early breast cancer.
    Varghese P; Mostafa A; Abdel-Rahman AT; Akberali S; Gattuso J; Canizales A; Wells CA; Carpenter R
    Eur J Surg Oncol; 2007 Mar; 33(2):147-52. PubMed ID: 17081723
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Improved False-Negative Rates with Intraoperative Identification of Clipped Nodes in Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.
    Cabıoğlu N; Karanlık H; Kangal D; Özkurt E; Öner G; Sezen F; Yılmaz R; Tükenmez M; Önder S; İğci A; Özmen V; Dinççağ A; Engin G; Müslümanoğlu M
    Ann Surg Oncol; 2018 Oct; 25(10):3030-3036. PubMed ID: 29978371
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sentinel node biopsy performed before preoperative chemotherapy for axillary lymph node staging in breast cancer.
    Schrenk P; Hochreiner G; Fridrik M; Wayand W
    Breast J; 2003; 9(4):282-7. PubMed ID: 12846861
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Subareolar blue dye only injection sentinel lymph node biopsy could reduce the numbers of standard axillary lymph node dissection in environments without access to nuclear medicine.
    Kavallaris A; Camara O; Runnebaum IB
    J Cancer Res Clin Oncol; 2008 Jun; 134(6):667-72. PubMed ID: 18026990
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy.
    Han SN; Amant F; Cardonick EH; Loibl S; Peccatori FA; Gheysens O; Sangalli CA; Nekljudova V; Steffensen KD; Mhallem Gziri M; Schröder CP; Lok CAR; Verest A; Neven P; Smeets A; Pruneri G; Cremonesi M; Gentilini O;
    Breast Cancer Res Treat; 2018 Apr; 168(2):551-557. PubMed ID: 29235045
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla.
    Bi Z; Liu J; Chen P; Liu Y; Zhao T; Wang C; Zhang Z; Sun X; Qiu P; Cong B; Song X; Wang Y
    Breast Cancer; 2019 May; 26(3):373-377. PubMed ID: 30666563
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
    van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.